Atlas Trials

Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer

Clinical trial NCT05168254 · UNKNOWN

Trial details

NCT number
NCT05168254
Sponsor
Ruijin Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Pancreatic Ductal Adenocarcinoma, PDAC
Start date
2021-01-01
Primary completion
2022-07-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.